Nordic Nanovector
2,25 NOK +42,41 %Vær den første som følger denne virksomhed
Nordic Nanovector is a pharmaceutical company. The company specializes in the development of antibody drugs for the treatment of hematological cancer. The greatest specialization is found in precision therapy used in the clinical phase. Other diseases that are treated are non-Hodgkin's lymphoma (NHL). The company was founded in 2009 and is headquartered in Oslo, Norway.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
NANOV
Daglig lav / høj pris
1,65 / 2,25
NOK
Markedsværdi
261,08 mio. NOK
Aktieomsætning
20,86 mio. NOK
Volumen
10 mio.
Finanskalender
Delårsrapport
31.08.2023
Viser Alle indholdstyper